|MDACC Study No:||2009-0847 (clinicaltrials.gov NCT No: NCT01102088)|
|Title:||Phase I/II Study of Evaluating the Safety and Efficacy of Using a Simultaneous Integrated Boost for Dose Escalation in Patients with Esophageal Cancer|
|Principal Investigator:||James Welsh|
|Treatment Agent:||5-Fluorouracil; Docetaxel; Radiation|
|Study Description:||The goal of this clinical research study is to find the highest tolerable dose |
of radiation that can be given in combination with chemotherapy in patients
with esophageal cancer that cannot be removed by surgery.